Be confident of medical device market approval
Since 25 May 2017, new regulations have applied to medical devices and active implantable devices marketed in the EU. The new EU Medical Device Regulation, (MDR (EU) 2017/745) will replace the EU directives on active implantable medical devices (90/385/EEC) after May 2020.
An active implantable medical device (AIMD) is any active medical device that is intended to be totally or partially introduced into the human body for diagnostic or therapeutic purposes, and which is intended to remain in place. AIMDs include a wide range of devices, including pacemakers, defibrillators, infusion pumps, ventricular assist systems and devices, cochlear implants and neurostimulators. Because AIMDs are designed to remain in direct contact with the body for extended periods, they are subject to rigorous standards and requirements to protect the health and safety of patients.
Directive 90/385/EEC of the European Union (EU) specifies the Essential Requirements manufacturers and importers must meet to apply the CE Mark and legally market or sell AIMDs in the EU. To demonstrate compliance with the requirements of the AIMD Directive, a manufacturer must develop technical documentation in order to properly evaluate their device. AIMD manufacturers must also establish a quality management system that complies with the Directive’s requirements.
TÜV SÜD Product Service is the world’s largest EU Notified Body for AIMDs and other medical devices.Our extensive network makes TÜV SÜD Product Service an effective single source for manufacturers seeking expertise in the testing and certification of AIMDs and other medical devices to EU requirements, as well as regulations applicable to medical devices in other major markets.
By achieving compliance with the Essential Requirements of the AIMD Directive, manufacturers may tap into the European market consisting of 500 million consumers. In addition, AIMDs bearing the CE Mark may achieve faster regulatory review and approval in other global markets.
Learn about the purpose of an EMC test plan and why the IEC 60601-1-2 4th ed requires one
How to ensure a smooth transition to MDR certification.
Covers clinical evidences required for in vitro diagnostics devices to enter the EU market
Select Your Location
Bosnia and Herzegovina